Olanzapine-Induced Rapid Weight Gain and Metabolic Disorders: A Case Series
Psychopharmacology Bulletin · 2026
DOI: 10.64719/pb.20785 ↗Kurz gefasst
Fallbericht in der Zeitschrift Psychopharmacology Bulletin, 2026. Verfasst von Michal Smogur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Smogur, Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University …. Hauptthemen laut MEDLINE: Olanzapine, Weight Gain, Antipsychotic Agents, Metabolic Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Olanzapine is an atypical antipsychotic drug associated with a high risk of weight gain and metabolic disorders. This condition represents both a major health risk for patients and a therapeutic challenge in psychiatric care. We present a series of four cases exhibiting a rapid and severe weight gain under olanzapine treatment, as well as new-onset metabolic syndrome in three of them. The evolution of these disorders after treatment modification is presented for three cases, and strategies for mitigating the risk of metabolic complications in patients receiving antipsychotic drugs are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Smogur, Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.
- Crettol, Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland. ORCID ID: 0000…
- Dubath, Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland. ORCID ID: 0000-…
- Vandenberghe, Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland. ORCID ID:…
- Schoretsanitis, Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland; Departm…
- Conus, Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland. ORCID ID: 0000-0002-5832-1910.
Zitieren
APA
Smogur, M., Crettol, S., Dubath, C., Vandenberghe, F., Schoretsanitis, G., Conus, P., Eap, C. B., & Ansermot, N. (2026). Olanzapine-Induced Rapid Weight Gain and Metabolic Disorders: A Case Series. Psychopharmacology Bulletin. https://doi.org/10.64719/pb.20785
Vancouver
Smogur M, Crettol S, Dubath C, Vandenberghe F, Schoretsanitis G, Conus P, et al. Olanzapine-Induced Rapid Weight Gain and Metabolic Disorders: A Case Series. Psychopharmacology Bulletin. 2026. doi:10.64719/pb.20785
BibTeX
@article{Smogur2026,
author = {Smogur, Michal and Crettol, Séverine and Dubath, Céline and Vandenberghe, Frederik and Schoretsanitis, Georgios and Conus, Philippe and Eap, Chin Bin and Ansermot, Nicolas},
title = {Olanzapine-Induced Rapid Weight Gain and Metabolic Disorders: A Case Series},
journal = {Psychopharmacology Bulletin},
year = {2026},
doi = {10.64719/pb.20785}
}
EUVIMED